Quality in diagnostic upper gastrointestinal endoscopy for the detection and surveillance of gastric cancer precursor lesions: Position paper of AEG, SEED and SEAP

Application of Dexmedetomidine in Surgical Anesthesia for Gastric Cancer and Its Effects on IL-1β, IL-6, TNF-α and CRP

“…General intravenous anesthesia is mostly used in radical surgery, comprising operations such as tracheal intubation during anesthesia. That would stimulate the sympathetic nerves, and induce strong stress reactions, hemodynamic changes and frequent brain electrical activities, which have adverse effects on the cardiovascular system and the smooth progress of surgery (8,9). In addition, patients who undergo radical surgery generally experience a certain amount of pain, mechanical stress in the gastrointestinal tract and local tissue damage, which will release a large amount of inflammatory mediators, increasing the incision infection, lung infection and other complications rates (10,11).…”

Endoscopic surveillance for familial intestinal gastric cancer in low‐incidence areas: An effective strategy

“…Contrarily to other syndromes, such as in HDGC where the surveillance is better established, 21,22 in FIGC there is no clear evidence for the best approach. Surveillance is recommended in a research environment, 23 and recommendations vary between different European societies, from just eradicating Hp , to performing endoscopies with different periodicities (annually, every 3 or 5 years) 2,4,24‐27 . For example, the European Society of Digestive Oncology expert panel recommends annual EGD with a detailed exploration of the gastric mucosa with random biopsies, starting at the latest at the age of 40 years or 5 years before disease onset in the youngest affected relative 24 .…”

“…Surveillance is recommended in a research environment, 23 and recommendations vary between different European societies, from just eradicating Hp, to performing endoscopies with different periodicities (annually, every 3 or 5 years). 2,4,[24][25][26][27] For example, the European Society of Digestive Oncology expert panel recommends annual EGD with a detailed exploration of the gastric mucosa with random biopsies, starting at the latest at the age of 40 years or 5 years before disease onset in the youngest affected relative. 24 However, there are no studies evaluating the effectiveness of the endoscopic assessment in FIGC.…”